Acute Porphyria Drugs

J02AX01 - Flucytosine

Probably not porphyrinogenic
PNP

Rationale
Given in gram doses but probably not significantly metabolised. No data pointing to CYP affinity. Four references state non-porphyrinogenicity.
Chemical description
Antimycotic pyrimidine derivative in systemic use (infusion of 1g x 4) in sepsis, meningitis, endocarditis etc. Excreted mainly in unchanged form by the kidneys, small amounts converted to fluorouracil. No indications of CYP-interaction.
Similar drugs
Explore alternative drugs in similar therapeutic classes J02A / J02AX or go back.
References
# Citation details PubMed ID
Porphyria Drug Lists
1. Australian List
Australian Porphyria Association No longer maintained
2. French List
Centre Français des Porphyries
3. EPI List
European Porphyria Initiative No longer maintained
4. South African List
Porphyria South Africa No longer maintained
Tradenames

Ancotil Ancotil Ancotil Ancotil Ancotil · Flucytosine Ancotil · Flucytosine Ancotil · Flucytosine Ancotil Ancotosin · Flusynerg Alcobon · Ancotil Ancotil · Flucytosine Ancotil
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙